Evidence map›Paper›PMID 41535291›Full record

ArticleNature communications2026

Dynamic allele usage of X-linked genes ameliorates neurodevelopmental disease phenotypes in brain organoids.

M Bertin, H Todorov, S Frank, S Käseberg, R Menon, E Gabassi, C Foerster, N Bobon, F Furlanetto, A Soliman and 23 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

M Bertin *Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
H Todorov *Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-2734-7701
S Frank *Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-3339-8495
S KäsebergInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-7882-5745
R MenonInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
E GabassiInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0001-6053-503X
C FoersterInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
N BobonDepartment of Biology, Johannes Gutenberg University Mainz, Mainz, Germany.
F FurlanettoInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0003-0963-3560
A SolimanInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0009-0001-8368-908X
H M B IbrahimInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-4319-7048
V EngelhardtInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0009-0004-9674-2742
L BirschmannInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0009-0009-4753-031X
H BrennenstuhlDivision of Child Neurology and Metabolic Medicine, Center for Child and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6909-0003
B LohrerInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
A Mas-SanchezInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
E CesareDepartment of Industrial Engineering, Università degli studi di Padova, Padova, Italy.
J WinterInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
J KrummeichInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
J WinklerDepartment of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0003-0630-9204
B WinnerDepartment of Stem Cell Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID http://orcid.org/0000-0002-6909-0564
E WeisInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
S DiederichInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
K LuckInstitute of Molecular Biology (IMB), Mainz, Germany.
P LuntCentre for Academic Child Health, University of Bristol, Bristol, UK.
S GerberInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0001-9513-0729
P BaumannDepartment of Biology, Johannes Gutenberg University Mainz, Mainz, Germany.
N ElvassoreDepartment of Industrial Engineering, Università degli studi di Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-7029-6287
B BerningerInstitute of Physiological Chemistry, University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-2652-2782
M F BasilicataInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-1111-9459
S SchweigerInstitute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. schweigs@uni-mainz.de.
S FalkInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. sven.falk@fau.de.ORCID http://orcid.org/0000-0003-4194-9274
M KarowInstitute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. marisa.karow@fau.de.ORCID http://orcid.org/0000-0003-4935-1365

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 460333672Deutsche Forschungsgemeinschaft (German Research Foundation) GRK2162/2 TP C2Wellcome Trust FC001002
6 · The paper itself

Abstract

While random X-chromosome inactivation in female cells of placental mammals silences one allele of the majority of X-chromosomal genes, a considerable fraction is only incompletely and variably inactivated. Human model systems to study the dynamics of incomplete X-inactivation are limited mostly to postmortem tissue, thereby disregarding developmental trajectories. Here, we used clonal human female induced pluripotent stem cells to track allele-specific expression of X-chromosomal genes along neural differentiation. We discovered dynamic reactivation and late-silencing of gene expression from the inactive X-chromosome leading to differentiation-induced locus- and lineage-specific usage of the two X-chromosomal alleles. In brain organoids modeling Opitz BBB/G syndrome, an X-linked neurodevelopmental disorder, reactivation of alleles from the inactive X-chromosome rescued cellular phenotypes and led to intermediate manifestations in female tissue. Taken together, our data demonstrate that alleles on the inactive X-chromosome can serve as a critical reservoir dynamically used during differentiation, thereby enhancing resilience of female neural tissue.

Indexed as

BrainGenes, X-LinkedNeurodevelopmental DisordersOrganoidsAllelesCell DifferentiationChromosomes, Human, XFemaleHumansInduced Pluripotent Stem CellsPhenotypeX Chromosome Inactivation

Identifiers

PMID41535291
PMCPMC12808108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.